Experimental cell transplant aims to free patients from insulin shots
NCT ID NCT01909245
Summary
This study is testing whether transplanting insulin-producing cells from donors into people with Type 1 diabetes is a safe and effective treatment. The procedure aims to help patients achieve better blood sugar control and potentially become independent from daily insulin injections. Participants will receive special anti-rejection medications and be followed for five years to see how well the transplanted cells work.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.